Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Pds Biotechnology Corp.
Headquarters: Florham Park, NJ, United States of America
Website: http://www.pdsbiotech.com
Year Founded: 2006
Status: Public
Industry Sector: HealthTechnology
CEO: Frank K. Bedu-Addo, PhD
Number Of Employees: 25
Enterprise Value: $121,122,838
PE Ratio: -1.08
Exchange/Ticker 1: NASDAQ:PDSB
Exchange/Ticker 2: N/A
Latest Market Cap: $56,182,800
BioCentury | Jan 24, 2024
Management Tracks
Markison to succeed Heino as Lantheus CEO
Plus: Lisa Olson becomes CEO of Enthera, and updates from Bayer, Neumora, PDS and more
BioCentury | Nov 30, 2023
Management Tracks
Kerr, Zimmermann leaving Generation Bio amid restructuring, headcount cuts
Plus: Sáez becomes Agomab’s chief development officer and updates from Forest Road, PDS, enGene and Pyxis
BioCentury | May 26, 2023
Product Development
May 26 ASCO Quick Takes: BMS’s Reblozyl headed for SOC in first-line MDS
Plus: Zentalis’ azenosertib shows early promise in ovarian cancer, and updates from PDS and Elevation
BioCentury | Jun 4, 2022
Management Tracks
Three new executives at Freenome
Plus Andersen new CFO at FibroBiologics and updates from Bexion, Concarlo and more
BioCentury | May 19, 2022
Management Tracks
AbbVie’s Pappalardo joins Fresenius as CMO for North America
Plus SOBI’s Batten joins Veru, and updates from FlandersBio, Google Health, Morphic and more
BioCentury | Oct 6, 2021
Management Tracks
Weinstein becomes CFO at Caris Life Sciences
Plus: Kezar, PDS, aTyr, Rosewell, Orum and more
BioCentury | Feb 4, 2021
Management Tracks
Novo Foundation names Krogsgaard Thomsen CEO; plus Takeda’s Sequeira to become first woman to chair PhRMA and updates from Almirall, Twist, Oncosec and more
Biomedical research foundation Novo Nordisk Foundation named Mads Krogsgaard Thomsen, EVP and CSO at Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO) as CEO, effective March 1. He replaces Birgitte
BioCentury | Jun 18, 2020
Product Development
Vaccines from CureVac, Imperial enter the clinic as PDS finds a partner for its product
The WHO halted, for a second time, the hydroxychloroquine arm of its SOLIDARITY trial
BioCentury | Apr 17, 2020
Product Development
BARDA’s $483M commitment to Moderna headlines flurry of COVID-19 vaccine updates
Inovio receives CEPI grant; Sinovac-Dynavax, Soligenix-Boston Scientific in adjuvant deals
BioCentury | Aug 13, 2019
Company News
Management tracks: Chouraqui leaving Novartis; plus iTeos, Immunovant, Biodesix
Items per page:
1 - 10 of 14